Zinda Michael 4
4 · Repare Therapeutics Inc. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Zinda Michael
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Common Shares
2024-03-01+14,000→ 74,118 total - Award
Employee Stock Option (right to buy)
2024-03-01+85,000→ 85,000 totalExercise: $6.95Exp: 2034-02-28→ Common Shares (85,000 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of March 1, 2025, March 1, 2026 and March 1, 2027, subject to Reporting Person continuing to provide service through each such date.
- [F2]Twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2025, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.